ArticleCancer research and treatment2019

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Ning Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.